Clare Scott leads an ovarian cancer laboratory focused on developing targeted therapies for ovarian cancer. Its aim is to change the current treatment paradigm of "one size fits all" for women with ovarian cancer. This involves the use of novel pre-clinical models of epithelial ovarian cancer, complementing my activities as a medical oncologist in breast and ovarian cancer.
They focus on designing novel treatments targeted to specific molecules that are altered in epithelial ovarian cancer, with an emphasis on unraveling the causes of drug resistance.
Org chart
Sign up to view 0 direct reports
Get started